The Angiogenesis Foundation
Template:Short description Script error: No such module "Infobox".Script error: No such module "Check for conflicting parameters".Script error: No such module "Check for unknown parameters".
The Angiogenesis Foundation, is a United States 501(c)(3) nonprofit organization established in 1994 for the study of angiogenesis. The foundation developed a therapy for canine cancer, called the Navy Protocol. This treatment works by starving the tumor of its blood supply.[1] In 2004, they helped publicly launch the first antiangiogenic therapy for cancer, bevacizumab, starting with colorectal cancer.[2] In 2010, the president and co-founder of the Angiogenesis Foundation, William Li, gave a well-received presentation at the TED conference on cancer prevention through antiangiogenic nutrition.[3]
Co-founder Dr. William Li won the 2024 Dr. Andrew von Eschenbach Award for his work in angiogenesis.[4]
References
<templatestyles src="Reflist/styles.css" />
- ↑ Dog's tale of survival opens door in cancer research, July 24, 2002
- ↑ Colon cancer drug seen as long awaited victory, February 26, 2004
- ↑ Script error: No such module "Citation/CS1".
- ↑ The Angiogenesis Foundation Chief Executive Officer Dr. William Li Was Honored As the Inaugural Recipient of the Dr. Andrew Von Eschenbach Award
Script error: No such module "Check for unknown parameters".